SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-041044
Filing Date
2020-08-24
Accepted
2020-08-24 16:01:19
Documents
14
Period of Report
2020-08-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20200824.htm   iXBRL 8-K 35727
2 EX-99.1 odt-ex991_24.htm EX-99.1 23327
3 GRAPHIC gul0n5t55pxn000001.jpg GRAPHIC 10862
  Complete submission text file 0001564590-20-041044.txt   213394

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA odt-20200824.xsd EX-101.SCH 5769
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20200824_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20200824_pre.xml EX-101.PRE 12079
7 EXTRACTED XBRL INSTANCE DOCUMENT odt-8k_20200824_htm.xml XML 3685
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 201127868
SIC: 2834 Pharmaceutical Preparations